Thursday, April 26, 2018
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Skin & Cancer Associates, LLP Partners With Susquehanna Private Capital, LLC
(April 16, 2018)

BALA CYNWYD, Pa., April 16, 2018 /PRNewswire/ -- Susquehanna Private Capital, LLC (SPC), a middle market private equity firm and member of the Susquehanna International Group of Companies (SIG), is pleased to announce its partnership with Skin & Cancer Associates, LLP (SCA), a dermatology group practice based in South Florida that is led by acclaimed dermatologists.

"We are thrilled to partner with SCA. The foundation for this partnership is our shared vision for executing a dermatologist-led strategy that prioritizes superb patient care," said Mark Miller, Director at SPC. "We are excited about the opportunities that lie ahead to advance the practice of dermatology as we seek to align with like-minded dermatologists throughout the country."

"SCA chose SPC as its partner because of its deep understanding of dermatology and its desire to sustain and build upon SCA's reputation for being a leader in clinical practice and practice management. With SPC's support, we expect to grow rapidly through new partnerships and to find innovative ways to positively impact the future of dermatology in the United States," said Reuven Porges, M.D., CEO of SCA.

"We believe SCA's dermatologists and management team are poised to create a national platform," said Leo Helmers, Co-Founder and Group Head of SPC. "We are honored to support this effort."

With support from Dr. Porges and a Board of Directors that includes representation from academic dermatology, SCA will continue to be led by its physicians and administrative personnel who have decades of experience supporting dermatology practices. SCA is actively pursuing new partnership opportunities.

About Skin and Cancer Associates
Founded in the early 70's and headquartered in the Fort Lauderdale, Florida metropolitan region, SCA is a partnership of over 25 dermatology practices. SCA provides care through over 40 Board-certified dermatologists, including prominent leaders. The Company's practices are supported by a scalable practice management infrastructure, which is led by David Wagener, MBA, CPA, and a CAPP accredited dermatopathology lab.

About Susquehanna Private Capital
SPC is an affiliate of Susquehanna International Group, LLP ("SIG"), one of the world's largest privately-held financial services firms. SPC makes majority and minority investments in domestic, middle market companies across a variety of industries, including: aerospace, defense & government, business services, consumer, food & beverage, healthcare, industrials, and technology, media & telecom. The firm is backed by a unique and patient capital base that gives management teams the freedom and flexibility to pursue business plans that maximize long-term value creation.

For additional information, please visit

Media Contact:           
David Wagener: [email protected]
Skin & Cancer Associates
1111 Park Centre Drive, Suite 300, Miami Gardens, FL 33169
Phone: (305) 623-5595 

Cision View original content:

SOURCE Skin and Cancer Associates

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Business,Science,Financial,Business Services,Medical,Cancer,Business,
Related Sites: DMN Newswire , ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter

  • Centene Corporation Reports 2018 First Quarter Results And Adjusts 2018 Guidance
  • "The Future of Getting Old" - With Old Age, New Possibilities
  • Analysis of Global "Medical Device & Accessories Market" Scope | Set for Rapid Growth 6.53% of CAGR during 2018 to 2023 | Topmost Players, Top Regional Trend & Segments |
  • Pain Management Device Market Factor Analysis 2018 - Technological and Product Development to Drive the Global Industry by 2023
  • Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases

  • World “Americas Interventional Radiology” Market Competitive Landscape with Phenomenal Growth CAGR 5.12% MRFR Unleashing Market Forecast by 2023
  • Research from Columbia Business School Measures Impact of New Cancer Drugs, Finds Most Significant Reduction in Mortality Rates 5-10 Years After Launch
  • Quality Cancer Care: Not Just a Matter of Anti-cancer Medicines
  • Global Biosensors Market 2018-2027: Rising Geriatric Population and Rapid Incorporation of Biosensing Technologies in Non-Medical Applications
  • "21+ Reasons Why" Showcases Support for Tobacco 21

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines